Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Youth with Hemoglobin SC Disease
NCT02336373Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxyurea in hemoglobin SC disease (HbSC), sponsored by Baylor College of Medicine. Primary endpoint: Pediatric Quality of Life Inventory Sickle Cell Disease Module version 3.0 at 6 months. Started Dec 2014; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
hemoglobin SC disease (HbSC)
Beyond the preview
Go deeper on NCT02336373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336373.